Innate Pharma: takeover bid conditions under review

Innate Pharma shareholders are reviewing the terms and conditions governing a potential takeover bid trigger.

Published 12sem1 sourceupdated 12sem

≈ 20sSpeed

The fact

This review comes against a backdrop of particular stock valuation for the French biotech.

Takeover bid terms remain at the heart of governance and value creation debates.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on April 16, 2026